Skip to main content
. Author manuscript; available in PMC: 2020 Feb 8.
Published in final edited form as: ACS Infect Dis. 2018 Dec 14;5(2):250–259. doi: 10.1021/acsinfecdis.8b00238

Figure 3.

Figure 3.

Tetracycline derivatives identified in the screen. Shown are the structures and names of the top tetracycline active compounds (IC50 < 10 μM) selected in the screening campaign.